Market Research Blog

Future Market Insights (FMI), in a recent report estimates global PEEK interbody devices market to grow steadily through 2021, despite COVID-19 pandemic creating a shift in administered care. The study pegs growth to hover above 7% mark throughout the forecast period.

Polyether ether ketone interbody devices are a significant breakthrough in the medical industry, with various healthcare settings adopting them to streamline their spinal implantation procedures. Additionally, they are highly eco-friendly as they are manufactured from organic thermoplastic polymers.

Provision of a bone-like modulus, high radiolucency to ensure accuracy and greater biocompatibility have all contributed to increasing PEEK interbody devices adoption for spinal procedures, and is likely to remain so in the future.

To remain ‘ahead’ of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-12685

Polyether Ether Ketone Interbody Devices Market Size (2022)
US$ 2.04 Bn
Revenue Forecast (2030)
US$ 3.72 Bn
Global Market Growth Rate (2022-2030)
7.8% CAGR
Dominant End User
Hospitals (48.9%)
Key Takeaways

US to retain market dominance; East Asia to be 2nd largest market through 2030
Surging popularity of minimally invasive surgeries to escalate interbody fusion devices growth
Hospitals to be key PEEK interbody devices end-users from 2020-2030
Rapid advancements in spinal implants to facilitate greater adoption
Fast-track regulatory approvals expanding sales across prominent regions
Global PEEK interbody devices to expand at 7.7% CAGR through 2030
“High incidence of degenerative disc diseases and spinal stenosis among the geriatrics is facilitating rapid innovations in surgical procedures, providing a wide base for PEEK interbody device market expansion,” opines the FMI analyst.

COVID-19 Impact Insights

The novel coronavirus pandemic has had varying impacts across the global polyether ether ketone interbody devices market. In the first stage, strict lockdowns and social distancing measures led to a drastic decline in industrial output, creating immense shortages of the devices across various healthcare settings.

Furthermore, greater emphasis was laid on caring for COVID-19 positive patients, leading to postponement of elective surgical procedures such as spinal correction or implantation, causing a substantial decline.

As the incidence of infections receded, the market has been experiencing a gradual incline. Flattening infection curves have enabled countries to ease lockdown restrictions, leading to a resumption of output which has largely balanced the demand-supply equation.

Moreover, spinal implant procedures are resuming, with hospitals and clinics registering a fall in the number of SARS-CoV-2 patients. Considering this recovery scenario, the global PEEK interbody devices is anticipated to rebound starting from 2021.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-12685

Competition Landscape

Prominent players within the global PEEK interbody devices landscape are Zimmer Biomet, Medtronic Plc, Stryker Corporation and Shandong Weigo Group. These and other players are focusing on expanding existing manufacturing capabilities, product innovations, forays into untapped markets and strengthening core competencies.

In June 2020, Zimmer Biomet announced the incorporation of new enhanced features of its mymobility® care management system which was introduced in collaboration with Apple in October 2018. These features will assist healthcare professionals to enhance decision-making processes concerning major surgeries by incorporating higher precision.

In October 2020, Medtronic plc reported that over 84% of chronic back pain patients treated with its DTMTM Spinal Cord Stimulation Therapy reported at least 50% pain relief since the system’s inception a year earlier. This has encouraged the company to keep investing in better pain management technologies.

Key Segments

Product Type

Posterolateral Fusion Devices
Interbody Fusion Devices
Anterior Lumbar Interbody Fusion Devices (ALIF)
Extreme Lateral Interbody Fusion Devices (XLIF)
Posterior Lumbar Interbody Fusion Devices (PLIF)
Transforaminal Lumbar Interbody Fusion Devices (TLIF)
Other Devices

End-Users

Hospitals
Ambulatory Surgical Centers
Specialty Clinics

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-12685

Region

North America (U.S & Canada)
Latin America (Brazil, Mexico, Argentina & Rest of Latin America)
Europe (Germany, Italy, France, U.K., Spain, BENELUX, Russia & Rest of Europe)
South Asia (India, Thailand, Indonesia, Malaysia & Rest of South Asia)
East Asia (China, Japan & South Korea)
Oceania (Australia & New Zealand)
Middle East & Africa (GCC, South Africa & Rest of MEA)

Stethoscope being an integral part of the modern medical diagnosis sector, has been gaining significant traction.

According to a recent study by Future Market Insights, the stethoscope market is forecast to expand at above 5% CAGR between 2020 and 2030.

Stethoscopes are often considered a physician’s third hand and the current digital advancements have ensured better performance.

The key market players such as American Diagnostic Corporation, 3M Company, Eco Devices Inc. and others are investing heavily to offer digitization of various medical tools.

They are focusing on technological advancements also gain competitive advantage in the global market.

The leading companies have started developing electronic stethoscopes in order to detect critical cardiovascular conditions much earlier than the normal stethoscopes can.

 Request for a sample @ 

https://www.futuremarketinsights.com/reports/sample/REP-GB-12675

The FMI report offers in-depth research and analysis of the global stethoscope market, its potential and growth scopes during the forecast period (2020-2030).

Some of the key takeaways from the report are as given below-

• The global stethoscope market is set to grow by 5.2% CAGR during the forecast period (2020-2030).

• Cardiovascular (CVS) disease being the main area of focus for the application of stethoscope in the medical sector, is to remain in the top factors for the increase in market demand
• By product acoustic stethoscope will keep leading the global market throughout the forecast period (2020-2030)
• Physician office, home care settings, hospitals and others to remain the top end-users catering to the market growth throughout the forecast period. Of these, demand from hospitals is set to be higher
• Region-wise North America and Latin America to lead the global market. Europe, South & East Asia, Oceania and MEA to sustain as other region-wise key players.

For critical insights, request for PDF Brochure @ 

https://www.futuremarketinsights.com/reports/brochure/rep-gb-12675

Rising Focus on Health and Wellbeing Boosting Growth

As people are getting more conscious about their health and well-being, the digitized sectors like stethoscope market is anticipated to expand further during the forecast period, reaching US$ ~ 914 Mn by the end of the year 2030.

The recent COVID-19 pandemic has even accelerated the growth of medical diagnosis which is resulting in the steady market growth over the years in future.

Currently the global stethoscope market holds unlimited opportunities for the global market players and so, the dominant market holders have already started adopting various digitized tools and procedure to remain in the top places.

For instance, the digital Eko CORE has brought their advanced algorithms which can automatically screen patients and is capable of providing up to 40x amplification of acoustic sound along with advanced noise elimination technology, as well as the modern flexible feature of switching between digital and acoustic modes.

COVID-19 Impact Analysis

Due the outbreak of novel coronavirus during the recent time, the demand of modern digitized stethoscopes has increased across the countries. The pandemic has created more awareness among the people as well as there is surge in the need of getting diagnosed earlier than the other times.

These altogether have increased the global stethoscope market demand among the top end-users, starting from physicians to hospitals or home care providers.

As the increased concern regarding health, especially heart and lungs related issues tends to sustain, the COVID-19 impact on the global stethoscope market will be long-lasting, opening endless opportunities to the market players during the forecast period.

Who is winning?

The global stethoscope market being emerged as a highly potential domain for the market dominating companies, the key market holders are evolving by adoption of various modern technologies.

The leading Companies like, Think Labs Medical LLC, Rudolf Riester GmbH, Meditech Equipment Co., Ltd. and others have started their research and release of various brand-new products to expand further throughout the forecast period (2020-2030).

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

[269 Pages] The global biological and chemical indicators market is expected to reach $457.8 million in 2022, with a 7.2 percent CAGR indicating positive market growth over the forecast period.

The global biological and chemical indicators market is expected to reach $457.8 million in 2022, with a 7.2 percent CAGR indicating positive market growth over the forecast period.

According to Future Market Insights (FMI) the worldwide yearly tracker, vendor revenue in global biological & chemical indicators market will grow 9.1% year over year to 396.8 Mn in 2020. Global shipments will rise 9.7% year over year to 830.7 Mn units in 2020.

Irrespective of the COVID-19 pandemic, demand for biological and chemical indicators has been surging tremendously as sterilization has always been at forefront of duties of healthcare facilities.

However, the role will be put to test in near future as epidemiological numbers continue to rise amidst the public health crisis. As such, FMI foresees healthy growth trail for global biological and chemical indicators market over forecast period 2020-2030.

Get Sample Report@  https://www.futuremarketinsights.com/reports/sample/rep-gb-12544

“After oral administration, parenteral dosage is the most prevalent way of providing drugs to patients. At present, about 95% of recently approved biopharmaceuticals are parenteral dosage form. This rise in commercialization and manufacturing of parenteral drugs will propel the adoption of biological and chemical indicators in biopharmaceuticals companies,” says analyst at FMI.

COVID-19 Impact on Biological & Chemical Indicators Market

The COVID-19 pandemic will trigger the demand for biological and chemical indicators for short-term to validate sterilization process in hospitals, ambulatory surgical centers (ASC), and clinics.

The pandemic has put pressure on frontline healthcare workers to follow strict cleaning and disinfection protocols as they are specifically at risk of contracting and spreading the infection. This has triggered the need for sterilization measures enacted during surgical procedures due to concerns of COVID-19 transmission among hospitalized patients.

The World Health Organization (WHO) has advised personal protective equipment (PPE) industry and governments to ramp up their manufacturing by 40% to cater to surging worldwide demand. This high pool of medical equipment with need for proper sterilization will bode well for biological & chemical indicators market in immediate future.

 Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-12544

Biological & Chemical Indicators Market – Competitive Intelligence

The global biological & chemical indicators market is highly consolidated with top 5 players – 3M Company, Steris Plc., and Thermo Fisher – collectively accounting for around 4/5 of overall market revenue. In order to sustain competition due to increasing number of new and small companies, leading players are focusing on mergers and acquisitions (M&A). For instance,

• Thermo Fisher Scientific Inc. has acquired QIAGEN N.V. – leading worldwide provider of sample preparation and molecular diagnostics technologies. This acquisition will enable the company to leverage its industry-leading capabilities and R&D expertise to speed up innovation and deal with emerging healthcare needs.
• McKesson Medical-Surgical Inc. has entered into an agreement with Walgreens Boots Alliance to combine their respective pharmaceutical wholesale businesses in Germany.
• Cantel Medical has taken over Hu-Friedy, which manufactures dental instruments and reprocessing equipment.

Want to Know More About Biological & Chemical Indicators Market?

Future Market Insights, in its new study, provides compelling insights about the biological & chemical indicators market that encloses industry analysis for 2015 – 2019 and opportunity assessment for 2020 – 2030. The report offers unbiased assessment on biological & chemical indicators market through five different categories – sterilization type, indicator class, packaging form, end user, and region. The global biological & chemical indicators market research study delivers insights of pricing by different life cycle analysis, product life cycle, major market trends and technologies that are being utilized in the development of biological & chemical indicators and product adoption in various end users.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-12544

Biological & Chemical Indicators Market Segmentation Sterilization Type

• Thermal Sterilization
  • Steam Heat
  • Dry Heat
• Chemical Sterilization
  • Ethylene Oxide
  • Hydrogen Peroxide
  • Formaldehyde
• Radiation Sterilization

Indicator Class

• Biological Indicators
  • Bacillus atrophaeus (BA) Spores
  • Geobacillus stearothermophilus (GS) Spores
  • Others
• Chemical Indicators
  • Class 1 (Process)
  • Class 4 (Multi-Variable)
  • Class 2 (Specific-Use)
  • Class 3 (Single-Variable)
  • Class 5 (Integrating)
  • Class 6 (Cycle Verification)
• Enzyme Indicators

Packaging Form

• Self-Contained BI
• Spore Suspension BI
• Strip and Disc BI
• Strip and Disc CI
• Others

End User

• Biopharma Industry
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Diagnostic Labs
• Research Labs

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 8-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Timely drug delivery is the cornerstone of an effective healthcare infrastructure. Rising prevalence of chronic and infectious ailments have accelerated production of prescription drugs, prompting vendors to develop effective distribution networks.

The COVID-19 pandemic has prompted the healthcare industry to run into an overdrive mode, ceaselessly working to find a potential cure for this deadly virus. As the world economy heads toward a recession, the enteral feeding devices market shall remain afloat.

As infected patients experience digestive problems, the demand for alternative food administration sources has risen. This has upticked the deployment of enteral feeding device on an increased frequency. Additionally, vendors are concentrating on strengthening regional distribution networks to ensure uninterrupted supply of equipment to various healthcare settings and organizations.

Demand across the United States, Brazil and India will especially remain strong, given the fact that these are the worst affected countries, providing immense scope for revenue generation to prominent manufacturers.

As healthcare infrastructure has improved, life expectancy has raised its bar. While this is welcome news, the rapidly proliferating geriatric population has also led to increased incidence of age-related ailments, both malignant and non-malignant. Conditions such as cancer, multiple sclerosis, dementia and brain damage have increased multifold.

All the aforementioned conditions have a deleterious impact on the patient’s digestive system, causing dyspepsia, throat and mouth pain, diarrhea and IBS. These co-morbidities render it impossible for patients to consume solid food. Hence, healthcare providers are accelerating the adoption of enteral feeding devices and provide adequate nutrients to patients.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-12403

Global Enteral Feeding Devices Market- Key Findings

• Enteral feeding devices market to expand at 6.6% CAGR from 2020-2030
• Oncology remains principal application area, neurological disorders to generate green spaces
• Nasoenteric feeding tubes to share the revenue pie with feeding pumps, attributed to effectiveness of nutrient delivery
• Homecare settings garnering major traction due to launch of easy-to-use and consumer friendly devices
• East & South Asia will emerge as potential revenue hotspots during the forecast period

“The global enteral feeding devices is in its growth stage, prompting vendors to flood the market with innovative and technologically advanced products, bringing the markets one step closer towards maturity,” infers the FMI analyst.

Competitive Landscape

Prominent players in the enteral feeding devices market include ICU Medical, Boston Scientific Corporation, Fresenius Kabi, Abbott Laboratories, Cook Medical, Cardinal Health, Inc., Becton Dickinson & Company and Dynarex Corporation among others. Besides this, a number of regional players also dominate the landscape.

In 2014, Cook Medical launched the Entuit Thrive Balloon Retention Gastronomy Feeding Tube for gastronomy and gastropexy procedures. This launch was a part and parcel of the company’s efforts to expand its enteral feeding devices product pipeline.

Boston Scientific Corporation markets a broad range of enteral devices such as the EndoVive Enteral Feeding Tube Kits. To expand its gastroenterology product portfolio, the company announced a limited market release of its Exalt Model-D single-use duodenoscope in January 2020.

In 2016, Cardinal Health launched its Kangaroo Joey Enteral Feed and Flush Pump to expand its adult nasogastric feeding tubes portfolio.

ICU Medical markets the Lopez Valve and EnFit Lopez Valve Closed Enteral Tubes which provide protection from accidental exposure to infectious body fluids to healthcare workers.

More Insights on the Enteral Feeding Devices Market

A recent market study published by FMI on the Enteral Feeding Devices market includes the global industry analysis of 2015-2019 & opportunity assessment for 2020-2030, and delivers a comprehensive assessment of the most important market dynamics. The report involved detailed segmentation on the basis of product type, application, age-group, end-user and region. Our analysts have conducted thorough research on the historical as well as current growth parameters of the market to obtain growth prospects with maximum precision.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-12403

Enteral Feeding Devices Market: SegmentationProduct Type

• Enteral Feeding Pumps
• Enteral Feeding Tubes
• Enterostomy Feeding Tubes
• Standard Tubes
• Standard Gastrostomy Tubes
• Standard Jejunostomy Tubes
• Standard Gastrojejunostromy Tubes
• Low Profile Tubes
• Low-profile Gastrostomy Tubes
• Low-profile Jejunostomy Tubes
• Nasoenteric Feeding Tubes
• Nasogastric Feeding Tubes
• Nasojejunal Feeding Tubes
• Nasoduodenal Feeding Tubes
• Oroenteric Feeding Tubes
• Administration Sets
• Enteral Syringes
• Consumables

Application

• Oncology
• Gastroenterology
• Diabetes
• Neurological Disorders
• Others

Age Group

• Adult
• Pediatric

End-user

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Homecare Settings
• Others

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-12403

Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Middle East & Africa

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

The USD 3 billion compression therapy market is likely to grow witness 6% CAGR through 2030, despite the COVID-19 blip, according to market research firm Future Market Insights. According to a latest study that tracks compression therapy adoption and market analysis in 20+ countries, the long-term outlook remains optimistic.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Future Market Insights (FMI), in its latest report, has revised the global orthopedic braces market growth projection to 6.9% CAGR through 2024. This revised projection considers the sluggishness induced due to the COVID-19 pandemic.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Digital ovulation tests help women to maximize the chances of conceiving naturally by identifying the two most fertile days of their menstrual cycle by measuring the changes in the level of luteinizing hormone (LH), which is important to fertility parameters. According to Future Market Insights (FMI) the U.S. digital ovulation test kits market is estimated to be US$ 80 Mn in 2021, and is expected to grow at a market CAGR of 9.6% during the forecast period (2021-2031)

[434 Pages] According to Future Market Insights (FMI), the demand for pharmaceutical caps and closures is expected to rise considerably, enabling the market to surpass US$ 2.27 Bn in valuation by the end of 2021.

Continuous advancements in research and development for drug supplements is a key factor speeding up packaging innovations. Advanced technologies used in packaging primarily focus on ensuring stability of drugs during storage, shipment, and delivery.

In the coming years, the rising cases of chronic disease will support the expansion of the market. The role of smart packaging for medication is increasing to offer greater precision of administered medication, which directly affects patient compliance. This will influence the adoption of cost-effective yet advanced packaging solutions among manufacturers.

The pharmaceutical caps and closures market will therefore register adoption of digital manufacturing. This technology offers high quality caps and closure, with minimal time and cost requirements.

Focus on reducing product damage by user has encouraged inventors to introduce multi-dose delivery caps. The product’s user can remove fluid from the vial by interfacing a needle to the cap. The smart cap ensures that leftover fluid is clean.

In the past few years, environmental awareness among consumers has increased the need for sustainable packaging. In pharmaceutical packaging, the primary concern is product stability.

The demand for reducing the risk of cross contamination of product drives the use of biodegradable material in caps and closures. Also, waste product management is a key concern. Environmentally-friendly material produce lesser waste and are also recyclable.

Despite this, plastics remain the preferred material for manufacturing caps and closures. Plastic use in the market is expected to rise at 6.4% as producers aim for greater flexibility.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-13237

Key Takeaways from Pharmaceutical caps and closures Services Market Study

• Despite restricted growth amid COVID-19, the demand for pharmaceutical caps and closures is expected to rise at nearly 5% CAGR in 2021.
• Increasing focus on light weight packaging is driving a transition towards resin-based packaging material.
• The U.K. and Germany are leading markets in Europe, accounting for more than 26% and 17% of the Europe market respectively in 2021
• The U.S. will account for a dominant share of 89% in the North America market through the forecast period.
• China is the largest and fastest growing market in East Asia, exhibiting 8% CAGR through 2031.

“Increasing demand for smart and safe packaging solutions for pharmaceuticals, besides favorable reimbursement policies will offer lucrative growth opportunities for pharmaceutical caps and closure manufacturers through the assessment period in 2031,” says the FMI analyst.

Increase in Funding for Research Activities Offers Growth Opportunities

Leading manufacturers in the pharmaceutical caps and closures market are strengthening their market position through collaboration with various other organizations. Governments in developed and developing countries are actively taking initiatives to encourage research pharmaceutical packaging products.

For instance, Voltaren “No Mess” applicator from GSK Consumer Health was co-developed with Neopac and Nypro Healthcare.

Big drug producers are expected to benefit from the globalization of labor forces, that is, employment of skilled local labor at cheaper rates to derive larger cost savings. Furthermore, this will create room for research and development (R&D) investments.

As per data from EFPIA and PhRMA, annual pharmaceutical (R&D) expenditures increased at 2.5% p.a. in Europe as compared to 3.3% p.a. in the U.S. over the latest measurable period 2016-2020. This will also create opportunities for the expansion of the market.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-13237

Who is winning?

The global market is set to expand due to the rising prevalence of chronic diseases. Leading organizations within the market are set to focus on research and development to offer an early and precise diagnosis of the ailment, besides offering effective patient care.

Some of the leading players in the pharmaceutical caps and closures market include but are not limited to Berry Global Inc., Amcor Plc, Aptar Inc., Closure Systems International Inc., O.Berk Company LLC, Bericap GmbH and Co KG, UNITED CAPS, CL Smith Company, Georg MENSHEN GmbH & Co. KG, WestRock Company, West Pharmaceutical Services Inc., Drug Plastics and Glass Co Inc., Gerresheimer AG, DWK Life Sciences GmbH, Parekhplast India Limited, and Parshva Exim Limited.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global pharmaceutical caps and closures market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the pharmaceutical caps and closures treatment market on basis of the main indication in detail, cover every aspect of the market such as product type, molecule type, application, and service provider across seven major regions.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-13237

Phramacutical caps and Closures Services Market by Category

Product type

• Screw Caps & Closure
• Snap Caps & Closure
• Push-Pull Caps & Closure
• Stopper & Seals
• Others

Functionality

• Child Resistant
• Tamper-evident

Material type

• Plastic
• Elastomer
• Metal

Avalability

• Prescription (Rx) Pharmaceuticals
• “Over-the-Counter (OTC) Pharmaceuticals”

Drug Modality

• Small Molecule (Synthetic Drugs)
• Biopharmaceuticals

Therapeutic class

• Anticancer Drugs
• Anti-infective Drugs
• Anti-viral Drugs
• Anti-bacterial Drugs
• Anti-fungal Drugs
• Others
• Cardiovascular Drugs
• Anti-inflammatory Drugs
• Analgesics Drugs
• Anti-diabetics
• Ophthalmic Drugs
• Neurological Drugs
• Others

End Users

• Pharmaceutical & Biotechnology Companies
• Contract Manufacturing  Organizations (CMO)
• Contract Research Organizations (CRO)
• Academic & Research Institutes

Region

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East and Africa (MEA)

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Sterilants sales will continue rising as focus on maintaining a clean and hygienic environment increases to prevent the spread of infections. Future Market Insights in a new study has predicted the sterilants market to reach US$ 2.31 Bn by 2021. Sterilants are chemical agents that destroy (or irreversibly inactivate) bacteria, fungi, and viruses, including their spores. They are also known as sporicides or sterilizers.

The sterilants market is expected to grow significantly in terms of revenue over the forecast period owing to the rising incidence of infectious disease transmission and surging demand for compatible sterilants. Among products available, the demand for ethylene oxide (EtO) is expected to remain considerably high. It is expected to account for over one-fourth sales in the market.

Get Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-13126

Demand for sterilants is poised to surge especially amid the COVID-19 outbreak. Consecutive waves of the pandemic has put hospitals and healthcare clinics under pressure to efficiently manage a rising footfall of patients. While the healthcare sector is pulling up the sleeves to contain the soaring number of cases infected with the virus, focus on maintaining a clean and hygienic environment is rising as well.

Healthcare organizations are adopting various policies to respond to the pandemic, one of them being increasing investment in sanitization and sterilants to prevent the risk of infection. Consequently, despite supply chain disruptions witnessed amid the crisis, the demand for sterilants will continue rising.

Key Takeaways from Sterilants Market Study

• Global sterilants market is estimated to rise at a CAGR of 5.9% during the forecast period (2021-2031)
• Presence of a sophisticated healthcare infrastructure and willingness to spend on health and hygiene will support sales in the U.S., which will account for 88% of the North America market in 2021
• Despite ongoing restriction to contain pandemic, the U.K. market will continue rising. In 2021 it is expected to register 4.3% y-o-y growth
• Expansion of the healthcare sector will creative conducive environment for growth in India
• Rising disposable income and favorable insurance policies will support the expansion of sterilants market in China

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-13126

 “Competition in the sterilants market is rising. Consequently the existing market players are likelier to focus on expansion strategies besides product launches. Some of them are entering into strategic collaborations will other companies,” says the FMI Analyst.

Development of Effective and Compatible Sterilants to Meet the End Users’ Demand is A Key Strategy for Sterilants Market Players

The leading manufacturers are focusing on research and development to develop effective and compatible sterilants that can meet the end users’ demand. The current pandemic outbreak and the growing global demand for multifunctional sterilizing products have led the manufacturers to increase their research efforts and expand their product portfolio through innovative product launches. For instance, in 2020, in response to the pandemic situation of the coronavirus outbreak, Lanxess launched a high-level disinfectant named Rely+On Virkon.

Key Participant Insights

Some of the companies covered by FMI include 3M Company, Steris Plc., Cantel Medical Corporation, Evonik Industries AG, Arkema S.A., Thor Group, Metrex Research, LLC, Ecolab Inc., Solvay SA, LANXESS, Contec, Inc., OZU Corporation, Cetylite, Inc., Veltek Associates, Inc., Whiteley Corporation, Gul Biyoloji Laboratuvari, and others. These players are consolidating their positions through mergers, acquisitions and new product launches.  Besides this they are adopting various strategies to consolidate their market share.

For instance, in 2021, Steris Plc acquired Cantel, a global provider of infection prevention products and services primarily for endoscopy and dental customers, by entering into a definitive agreement through a U.S. subsidiary.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-13126

Want More Insights?

Future Market Insights (FMI) brings a comprehensive research report on forecast revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global sterilants market is segmented in detail to cover every aspect of the market and present a complete market intelligence report to the reader. The study provides compelling insights on the sterilants market on basis of product type such as ethylene oxide (EtO), glutaraldehyde, hydrogen peroxide gas plasma (HPGP), vaporized hydrogen peroxide, immersion and vapor phase peracetic acid and others. Based on form, sterilants are segmented into liquids and sprays. Based on end-users, the market is segmented into hospitals, clinics, ambulatory surgical centers, diagnostic laboratories, reference laboratories, rehabilitation centers, long-term care centers, critical care centers, pharmaceutical & biotechnology companies, academics and research institutes and homecare settings.

Sterilants Market by Category

Product

• Ethylene Oxide (EtO)
• Glutaraldehyde
• Hydrogen Peroxide Gas Plasma (HPGP)
• Vaporized Hydrogen Peroxide
• Immersion and Vapor Phase Peracetic Acid
• Others

Form

• Liquid
• Spray

End-user

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Diagnostic Laboratories
• Reference Laboratories
• Rehabilitation Centers
• Long Term Care Centers
• Critical Care Centers
• Pharmaceutical & Biotechnology Companies
• Academics and Research Institutes
• Homecare Settings